JCR Pharmaceuticals Co., Ltd. (JCRRF)

OTCMKTS · Delayed Price · Currency is USD
4.170
-0.580 (-12.21%)
At close: Jan 30, 2026
Market Cap482.17M +12.5%
Revenue (ttm)239.46M +7.2%
Net Income-15.56M
EPS-0.13
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividend0.13 (3.14%)
Ex-Dividend DateMar 30, 2026
Volume500
Average Volume370
Open4.170
Previous Close4.750
Day's Range4.170 - 4.170
52-Week Range3.780 - 5.000
Beta-0.00
RSI13.62
Earnings DateMay 8, 2026

About JCR Pharmaceuticals

JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The comp... [Read more]

Sector Healthcare
Founded 1975
Employees 987
Stock Exchange OTCMKTS
Ticker Symbol JCRRF
Full Company Profile

Financial Performance

Financial numbers in JPY Financial Statements